8-K: HealthEquity Reports Record Q1 FY26 Revenue and Adjusted EBITDA, Raises Full-Year Guidance

HealthEquity, Inc. announced strong first quarter fiscal year 2026 financial results, including record revenue and Adjusted EBITDA, leading to an increase in its full-year fiscal 2026 guidance.

Summary

• HealthEquity reported first quarter fiscal year 2026 revenue of $330.8 million, a 15% increase compared to $287.6 million in Q1 FY25.
• Net income for Q1 FY26 was $53.9 million, an 87% increase from $28.8 million in Q1 FY25, with non-GAAP net income rising 22% to $85.8 million.
• Adjusted EBITDA reached a record $140.2 million, up 19% from $117.4 million in Q1 FY25, representing 42% of revenue.
• The company grew its Health Savings Accounts (HSAs) to 9.9 million, a 9% year-over-year increase, and total HSA Assets to $31.3 billion, up 15% year-over-year.
• Total Accounts, including HSAs and complementary Consumer-Directed Benefits (CDBs), increased 7% to 17.1 million.
• HealthEquity repurchased 0.7 million shares of its common stock for $60.3 million during the quarter, with $117.5 million remaining authorized under the program.
• Management increased its fiscal year 2026 outlook, now expecting revenues between $1.285 billion and $1.305 billion, and Adjusted EBITDA between $530 million and $550 million.

Sentiment

Score: 8

Explanation: The document conveys a highly positive sentiment, driven by strong financial performance, record-breaking revenue and Adjusted EBITDA, significant growth in key business metrics (HSAs, HSA assets), and an upward revision of full-year guidance. The active share repurchase program further reinforces positive shareholder sentiment. The only minor negative is a decrease in new HSAs from sales, but overall results are very strong.

Positives

• Revenue increased by 15% year-over-year to a record $330.8 million in Q1 FY26.
• Net income surged by 87% to $53.9 million, and non-GAAP net income grew by 22% to $85.8 million.
• Adjusted EBITDA rose by 19% to a record $140.2 million, with the Adjusted EBITDA margin improving to 42% of revenue.
• The company increased its full fiscal year 2026 guidance for revenue, net income, and Adjusted EBITDA, signaling strong confidence in future performance.
• Total HSAs grew by 9% year-over-year to 9.9 million, demonstrating continued account growth.
• Total HSA Assets increased by 15% year-over-year to $31.3 billion, indicating robust asset accumulation.
• HSAs with investments saw a significant 16% increase year-over-year to 770,000 accounts.
• The company actively engaged in share repurchases, buying back $60.3 million of common stock, which can be accretive to shareholder value.
• Enhanced member-first secure mobile experience to strengthen security, increase member resources, and reduce costs.

Negatives

• New HSAs from sales decreased by 23% quarter-to-date, from 194,000 in Q1 FY25 to 150,000 in Q1 FY26.
• Interest expense increased to $14.858 million in Q1 FY26 from $11.795 million in Q1 FY25.
• Cash and cash equivalents decreased from $295.948 million as of January 31, 2025, to $287.894 million as of April 30, 2025.

Risks

• Ability to adequately place and safeguard custodial assets, or the failure of any depository or insurance company partners.
• Ability to compete effectively in a rapidly evolving healthcare and benefits administration industry.
• Dependence on the continued availability and benefits of tax-advantaged HSAs and other Consumer-Directed Benefits (CDBs).
• Risks relating to the recent CEO transition.
• Impact of increased fraudulent account activity involving member accounts or third-party service providers on reputation and financial results.
• Ability to successfully identify, acquire, and integrate additional portfolio purchases or acquisition targets.
• Significant competition faced and potentially faced in the future, including from those with greater resources.
• Reliance on the availability and performance of technology and communications systems.
• Recent and potential future cybersecurity breaches of technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage, and loss of business.
• The current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations.
• Potential regulatory changes and changes in the enforcement environment under the new U.S. administration.
• Ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser, and other laws applicable to the business.
• Reliance on partners and third-party vendors for distribution and important services.
• Ability to develop and implement updated features for technology platforms and communications systems.
• Reliance on the management team and key team members.

Future Outlook

For the fiscal year ending January 31, 2026, HealthEquity management expects revenues of $1.285 billion to $1.305 billion, net income between $173 million and $188 million (or $1.96 to $2.13 per diluted share), non-GAAP net income between $320 million and $335 million (or $3.61 to $3.78 per diluted share), and Adjusted EBITDA between $530 million and $550 million. This outlook represents an increase from previous guidance, reflecting confidence in continued growth.

Management Comments

• "The HealthEquity team started fiscal 2026 with a strong first quarter that included record quarterly revenue, record Adjusted EBITDA, and increased guidance for the year," said Scott Cutler, President and CEO of HealthEquity.
• Scott Cutler also stated, "We enhanced our member-first secure mobile experience to strengthen the security of our members $31 billion of HSA Assets, increase member resources, and reduce costs."
• Scott Cutler further added, "We also applaud and support the efforts of our nations leaders to improve and empower healthcare consumers by expanding the benefits of HSAs, as well as extending eligibility to more American families."

Industry Context

HealthEquity operates in the rapidly evolving healthcare and benefits administration industry, specializing in Health Savings Accounts (HSAs) and other consumer-directed benefits. The company's strong growth in HSA assets and accounts, coupled with increased revenue and profitability, indicates its continued leadership and ability to capitalize on the increasing adoption of tax-advantaged healthcare savings solutions. The management's support for legislative efforts to expand HSA benefits aligns with broader industry trends aiming to empower healthcare consumers and improve financial wellness.

Comparison to Industry Standards

• The document does not provide specific comparable companies, projects, or results to assess HealthEquity's performance against global benchmarks or direct competitors. Therefore, a detailed comparison to industry standards based solely on this document is not possible.
• However, the reported 15% revenue growth and 19% Adjusted EBITDA growth year-over-year suggest a strong performance within the financial services and healthcare administration sectors, particularly given the scale of HealthEquity's operations as the nation's largest HSA custodian by number of accounts.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased guidance, and active share repurchase program, which can enhance shareholder value.
• Customers/Members: Positive impact through enhanced secure mobile experience, increased member resources, and the company's support for expanding HSA benefits.
• Employees: Strong company performance generally provides stability and potential opportunities, though no specific employee-related initiatives were detailed.

Next Steps

• HealthEquity management will host a conference call on Tuesday, June 3, 2025, at 4:30 pm (Eastern Time) to discuss the fiscal 2026 first quarter financial results.

Key Dates

Recommendation

Keywords

Health Savings Account, HSA, Consumer-Directed Benefits, CDB, Financial Results, Earnings, Healthcare, Benefits Administration, Custodial Assets, Adjusted EBITDA, Revenue, Net Income, Share Repurchase